Advance your academic career, collaborate globally, and expand your network— join now !

Dr. Marilena Vlachou

National and Kapodistrian University of Athens

Share Link

Share

Information

Dr. Marilena Vlachou is an Associate Professor at the National and Kapodistrian University of Athens (NKUA), Greece. She obtained her B.Pharm and Ph.D. (Pharmaceutical Technology) degrees from the NKUA. Just before obtaining her Ph.D., she moved to the University of Rhode Island, United States, as a Visiting Research Scientist to conduct cutting-edge research on Pharmaceutical Technology techniques. Her research interests include the formulation and in vitro release of bioactive substances from topical formulations, the efficacy and safety of formulations in skin disease therapies, the modified release of novel synthetic bioactive molecules, with diverse activity, the investigation of the physicochemical properties of new excipients, including those of marine origin (Ulvans), and nanomaterials, concerning their interaction with active pharmaceutical ingredients (APIs), 3D/4D printlets and AI-based pharmaceutical formulations’ development. Dr. Vlachou is a member of various scientific societies, including the Royal Society of Medicine, London, has published more than 75 research articles in peer-reviewed journals, and has been an invited speaker at many scientific conferences/symposiums.

Research Keywords & Expertise

Drug Delivery
PHARMACEUTICAL TECHNOL...
drug release
modified release
physical pharmacy

Fingerprints

33%
modified release
25%
Drug Delivery
18%
drug release

Short Biography

Dr. Marilena Vlachou is an Associate Professor at the National and Kapodistrian University of Athens (NKUA), Greece. She obtained her B.Pharm and Ph.D. (Pharmaceutical Technology) degrees from the NKUA. Just before obtaining her Ph.D., she moved to the University of Rhode Island, United States, as a Visiting Research Scientist to conduct cutting-edge research on Pharmaceutical Technology techniques. Her research interests include the formulation and in vitro release of bioactive substances from topical formulations, the efficacy and safety of formulations in skin disease therapies, the modified release of novel synthetic bioactive molecules, with diverse activity, the investigation of the physicochemical properties of new excipients, including those of marine origin (Ulvans), and nanomaterials, concerning their interaction with active pharmaceutical ingredients (APIs), 3D/4D printlets and AI-based pharmaceutical formulations’ development. Dr. Vlachou is a member of various scientific societies, including the Royal Society of Medicine, London, has published more than 75 research articles in peer-reviewed journals, and has been an invited speaker at many scientific conferences/symposiums.